![]() |
市场调查报告书
商品编码
1954614
培养皿市场规模、占有率、成长及全球产业分析:依类型、应用和地区划分的洞察与预测(2026-2034 年)Petri Dishes Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
2025 年全球培养皿市场规模为 4.295 亿美元,预计将从 2026 年的 4.468 亿美元增长至 2034 年的 6.461 亿美元,预测期内(2026-2034 年)复合年增长率 (CAGR) 为 4.70%。 2025 年,北美以 40.20% 的市占率领先。这得益于医药产业强大的研发投入和不断扩大的医疗基础设施。
培养皿是浅的、有盖的玻璃或塑胶培养皿,广泛用于微生物培养、抗生素疗效测试和微生物学研究。慢性病和传染病的日益普及推动了对药品、疫苗和治疗方法的需求,进而促进了研究活动,并增加了对培养皿等实验室设备的需求。
新冠疫情的影响
新冠疫情对全球市场产生了正面影响。与疫苗研发、治疗方法发现和慢性病研究相关的研究活动增加,促使实验室设备需求激增。
根据美国科学技术统计中心 (NCSE) 的数据,美国研发投资从 2019 年的 6,661.5 亿美元成长到 2020 年的 7,169.5 亿美元,增幅达 16.2%。赛默飞世尔科技 (Thermo Fisher Scientific) 2020 年生命科学解决方案部门的表现成长了 77.5%,反映了市场对实验室设备的强劲需求。疫情后的成长由于实验室用品的提前采购而趋于正常,但研究的扩展仍在继续支撑着市场的稳定发展。
市场趋势
对可生物分解实验室设备的兴趣日益浓厚
人们对一次性塑胶实验室设备的环境问题日益关注,推动了对可生物降解和可重复使用培养皿的需求。实验室和永续发展倡议正在推广环保的实验室实践。
例如,2022年11月,奥地利绿色实验室、默克集团和维也纳大学共同举办了一场关于永续实验室解决方案的研讨会。这些努力有望促进环保产品创新,并塑造未来的市场趋势。
市场驱动因素
医疗领域研发活动增加
随着全球传染病和慢性病病例的增加,製药业的研发投资正在扩大。这直接推动了对细胞培养皿及相关耗材的需求。
製药公司、合约研究组织 (CRO) 和合约生产商 (CMO) 之间日益密切的合作,进一步加速了研发活动和产品上市。
市场限制因子
替代品的日益普及
多孔板和 PCR 板的广泛应用对传统培养皿的普及构成了挑战。多孔板因其高通量和便利性,在高级研究应用中极具吸引力。
例如,赛默飞世尔科技 (Thermo Fisher) 的 96 孔微孔板售价约为 9-10 美元,而默克 (Merck) 的同类产品则以 4-5 美元的价格提供了更具成本效益的选择。此外,为减少塑胶垃圾,可重复使用的实验室设备的日益普及也可能限制需求成长。
依产品类型
市场区隔将培养皿分为塑胶培养皿和玻璃培养皿。
依最终使用者划分
市场细分包括医院和临床实验室、诊断中心、製药和生物技术公司、学术和研究机构以及其他机构。
北美
预计到2025年,北美将以1.726亿美元的市场估值引领市场。研发设施的扩张和製药投资正在推动成长。例如,赛默飞世尔科技于2023年3月在加州开设了一家细胞治疗中心,加速治疗药物的研发。
亚太地区
由于生物製药生产和分销中心的扩张,预计亚太地区将以可观的复合年增长率增长。 2023年7月,Avantar扩大了在新加坡的基地,以加强创新和其生物製药体系。
欧洲
欧洲占了较大的市场占有率,这得益于其在个人化医疗和永续实验室运作方面的努力。 2022年,SARSTEDT AG等公司推出了创新细胞培养板,旨在提高研究效率。
拉丁美洲、中东和非洲
由于製药业的合作以及医疗基础设施建设的进步,例如默克公司在尼日利亚的疫苗设施支持计划,预计这些地区将稳步增长。
The global petri dishes market was valued at USD 429.5 million in 2025 and is projected to grow from USD 446.8 million in 2026 to USD 646.1 million by 2034, exhibiting a CAGR of 4.70% during the forecast period (2026-2034). In 2025, North America dominated the market with a 40.20% share, supported by strong pharmaceutical R&D investments and expanding healthcare infrastructure.
Petri dishes are shallow, lidded plates made of glass or plastic, widely used for culturing microorganisms, testing antibiotic efficacy, and conducting microbiological research. Growing prevalence of chronic and infectious diseases is increasing the demand for drugs, vaccines, and therapies, thereby fueling research activities and boosting demand for labware products such as petri dishes.
COVID-19 Impact
The COVID-19 pandemic had a positive impact on the global market. Increased research activities related to vaccine development, treatment discovery, and chronic disease studies led to a surge in labware demand.
According to the National Center for Science and Engineering Statistics, U.S. R&D investment increased by 16.2% to USD 716.95 billion in 2020, compared to USD 666.15 billion in 2019. Thermo Fisher Scientific reported a 77.5% growth in its life sciences solutions segment in 2020, reflecting strong labware demand. Although growth normalized post-pandemic due to prior procurement of lab supplies, research expansion continues to support steady market progress.
Market Trends
Growing Focus on Biodegradable Labware
Environmental concerns surrounding single-use plastic labware are driving demand for biodegradable and reusable petri dishes. Research institutes and sustainability initiatives are encouraging green laboratory practices.
For example, in November 2022, Green Labs Austria, Merck KGaA, and the University of Vienna organized a workshop on sustainable lab solutions. Such initiatives are expected to promote eco-friendly product innovations and shape future market trends.
Market Drivers
Increasing R&D Activities in Healthcare
Rising global cases of infectious and chronic diseases are increasing pharmaceutical R&D investments. This directly drives demand for cell culture dishes and related consumables.
Growing collaborations between pharmaceutical companies, CROs, and CMOs are further accelerating research activities and product adoption.
Market Restraints
Rising Adoption of Alternatives
The increasing use of multiwell plates and PCR plates poses a challenge to traditional petri dish adoption. Multiwell plates offer high-throughput capabilities and convenience, making them attractive for advanced research applications.
For example, Thermo Fisher's 96-well microplates are priced around USD 9-10, while Merck's equivalent products cost USD 4-5, offering cost-efficient alternatives. Additionally, growing adoption of reusable labware to reduce plastic waste may limit demand growth.
By Product Type
The market is segmented into plastic and glass petri dishes.
By End-User
The market is segmented into hospital & clinical laboratories, diagnostic centers, pharmaceutical & biotechnology companies, academic & research institutes, and others.
North America
North America led the market with a valuation of USD 172.6 million in 2025. Growth is supported by expanding R&D facilities and pharmaceutical investments. For instance, in March 2023, Thermo Fisher opened a cell therapy facility in California to accelerate therapy development.
Asia Pacific
Asia Pacific is expected to grow at a considerable CAGR due to expanding biopharma manufacturing and distribution centers. In July 2023, Avantor expanded its Singapore hub to strengthen innovation and biopharma systems.
Europe
Europe holds a significant share, supported by personalized therapy initiatives and sustainable lab practices. Companies like SARSTEDT AG launched innovative cell culture plates in 2022 to enhance research efficiency.
Latin America & Middle East & Africa
These regions are expected to grow steadily due to increasing pharmaceutical collaborations and healthcare infrastructure development, such as Merck's vaccine facility support initiative in Nigeria.
Competitive Landscape
The market is fragmented, with leading players focusing on innovation, facility expansion, and partnerships. Key companies include:
Recent collaborations, product launches, and sustainability initiatives are strengthening competitive positioning.
Conclusion
The global petri dishes market is poised for steady growth, rising from USD 429.5 million in 2025 to USD 646.1 million by 2034, at a CAGR of 4.70%. Growth is primarily driven by expanding pharmaceutical R&D activities, increasing chronic disease prevalence, and advancements in cell culture research. While alternative labware products and sustainability concerns pose challenges, continuous innovation and rising global research investments will sustain market expansion through 2034.
Segmentation By Product Type
By End-user
By Region